Zhejiang Huakang Pharmaceutical Co Ltd - Class A

SHSE:605077 (China)   Class A
Â¥ 15.31 (+0.2%) Jun 21
13.10
P/B:
1.47
Market Cap:
Â¥ 4.67B ($ 643.05M)
Enterprise V:
Â¥ 5.28B ($ 727.83M)
Volume:
753.10K
Avg Vol (2M):
2.64M
Trade In:
Volume:
753.10K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Zhejiang Huakang Pharmaceutical Co Ltd ( SHSE:605077 ) from 2021 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Zhejiang Huakang Pharmaceutical stock (SHSE:605077) PE ratio as of Jun 22 2024 is 13.1. More Details

Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) PE Ratio (TTM) Chart

To

Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) PE Ratio (TTM) Historical Data

Total 819
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
Zhejiang Huakang Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-23 13.1 2024-04-18 13.1
2024-06-21 13.1 2024-04-17 12.7
2024-06-20 13.1 2024-04-16 12.3
2024-06-19 13.2 2024-04-15 12.7
2024-06-18 13.3 2024-04-12 12.9
2024-06-17 13.3 2024-04-11 13.0
2024-06-14 13.3 2024-04-10 13.0
2024-06-13 13.2 2024-04-09 13.3
2024-06-12 13.6 2024-04-08 13.0
2024-06-11 13.6 2024-04-05 13.3
2024-06-07 13.4 2024-04-03 13.3
2024-06-06 13.2 2024-04-02 13.3
2024-06-05 13.5 2024-04-01 13.2
2024-06-04 13.8 2024-03-29 12.8
2024-06-03 13.9 2024-03-28 12.7
2024-05-31 14.1 2024-03-27 11.8
2024-05-30 14.2 2024-03-26 11.9
2024-05-29 14.3 2024-03-25 11.9
2024-05-28 14.1 2024-03-22 12.1
2024-05-27 14.8 2024-03-21 12.4
2024-05-24 15.1 2024-03-20 12.6
2024-05-23 15.1 2024-03-19 12.5
2024-05-22 15.4 2024-03-18 12.6
2024-05-21 15.7 2024-03-15 12.5
2024-05-20 15.8 2024-03-14 12.4
2024-05-17 15.2 2024-03-13 12.5
2024-05-16 15.1 2024-03-12 12.4
2024-05-15 15.4 2024-03-11 12.2
2024-05-14 15.3 2024-03-08 12.1
2024-05-13 15.5 2024-03-07 11.9
2024-05-10 15.8 2024-03-06 11.8
2024-05-09 15.9 2024-03-05 11.8
2024-05-08 15.0 2024-03-04 12.1
2024-05-07 14.8 2024-03-01 12.0
2024-05-06 14.4 2024-02-29 12.1
2024-05-03 13.9 2024-02-28 12.0
2024-05-02 13.9 2024-02-27 12.8
2024-04-30 13.9 2024-02-26 12.4
2024-04-29 13.7 2024-02-23 12.6
2024-04-26 13.5 2024-02-22 11.7
2024-04-25 13.9 2024-02-21 11.6
2024-04-24 13.9 2024-02-20 11.5
2024-04-23 14.1 2024-02-19 11.5
2024-04-22 14.3 2024-02-16 11.5
2024-04-19 13.7 2024-02-09 11.5

Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.